Surat: Anupam Rasayan India Limited (BSE: 543275, NSE: ANURAS), a leading player in custom synthesis and specialty chemicals, reported exceptional financial results for the quarter ended September 30, 2025, marking one of its strongest performances to date.
The company’s consolidated revenue for Q2FY26 stood at ₹7,392 million, registering a staggering 149% year-on-year growth compared to ₹2,959 million in Q2FY25. This sharp rise reflects both robust demand and operational efficiency across its product portfolio.
EBITDA for the quarter reached ₹1,436 million, up 74% from ₹824 million in the same period last year. The EBITDA margin for Q2FY26 was reported at 19%, underscoring the company’s ability to maintain profitability amid rapid expansion.
Profit After Tax (PAT) came in at ₹572 million, an 87% increase over ₹306 million in Q2FY25, further reinforcing the company’s strong financial trajectory.
Commenting on the results, Managing Director Anand Desai stated, “Q2 FY26 has been one of the best quarters for our company. We delivered a stellar performance with consolidated revenue from operations of ₹739 crore, reflecting exceptional growth of 149% year-on-year and 51% sequentially.”
For the first half of FY26, Anupam Rasayan reported consolidated revenue of ₹1,229 crore, marking a 122% YoY growth. Notably, the company has already surpassed its total revenue for FY25 within just six months, a testament to its resilient business model, deep customer relationships, and operational excellence.
The company’s subsidiary, Tanfac Industries, also contributed significantly to the overall performance, posting revenue of ₹345 crore in H1 FY26 — a 67% year-on-year increase.
Anupam Rasayan’s consistent growth reflects its strategic focus on high-value chemical segments and its ability to scale operations while maintaining profitability. The company remains optimistic about sustaining this momentum through the remainder of FY26.
